1. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Issue 10220 (25th January 2020) Authors: Lotery, Andrew; Sivaprasad, Sobha; O'Connell, Abby; Harris, Rosie A; Culliford, Lucy; Ellis, Lucy; Cree, Angela; Madhusudhan, Savita; Behar-Cohen, Francine; Chakravarthy, Usha; Peto, Tunde; Rogers, Chris A; Reeves, Barnaby C Journal: Lancet Issue: Volume 395:Issue 10220(2019) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determination of a gene and environment risk model for age-related macular degeneration. Issue 10 (24th June 2010) Authors: Gibson, Jane; Cree, Angela; Collins, Andrew; Lotery, Andrew; Ennis, Sarah Journal: British journal of ophthalmology Issue: Volume 94:Issue 10(2010) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗